Hair-Like Soft Robot Captures Tumor Cells From All 23 Liver Cancer Patients Tested

CiliaVine Uses Magnetic Cilia to Control Blood Flow

Researchers from the Shenzhen Institute of Artificial Intelligence and Robotics for Society, The Chinese University of Hong Kong, and Chinese PLA General Hospital developed CiliaVine, a soft robot that manipulates blood flow using magnetic fields1

1

2

2

. The tiny hairy robot attaches to a medical guidewire and features 50 flexible hair-like structures called magnetic cilia. These structures move in programmable patterns when exposed to magnetic fields, disrupting the normally smooth layered movement of blood through vessels. This local disturbance allows the medical robotics device to push material toward vessel walls, draw it away, or create small vortices that mix surrounding fluid.

Targeted Drug Delivery Shows 146% Improvement

In laboratory tests, CiliaVine demonstrated significant improvements in targeted drug delivery. The amount of a model drug reaching the vessel wall increased by 146% compared to natural diffusion, while 75% more drug reached 1 millimeter beyond the vessel wall1

1

. Blood normally flows in smooth layers, making it difficult for drugs, particles, or cells to move sideways across the bloodstream. CiliaVine's ability to manipulate blood flow locally addresses this challenge, offering a way to deliver treatments more precisely to specific parts of the bloodstream rather than relying entirely on natural circulation.

Blood Clot Dissolution Accelerates by 43%

The soft robot also showed promise in speeding up blood clot dissolution when combined with tissue plasminogen activator, or tPA, a standard clot-busting drug. In vessel models treated with tPA, clots dissolved in approximately 40 minutes when CiliaVine was operating, compared to an average of 70 minutes without the device2

2

. This 43% reduction in dissolution time suggests that altering fluid movement around clots could help medications work faster and more effectively in treating conditions like stroke or deep vein thrombosis.

Device Captures Circulating Tumor Cells From All Liver Cancer Patients

Researchers coated CiliaVine with antibodies to test its potential for cancer diagnosis. The device captured circulating tumor cells from blood samples taken from all 23 liver cancer patients tested at Chinese PLA General Hospital1

1

2

2

. Circulating tumor cells are rare cancer cells released into the bloodstream that can indicate disease progression or metastasis. The 100% capture rate across all patients tested points to CiliaVine's potential as a monitoring tool that could help doctors track cancer development and treatment response more effectively than current methods.

Biomedical Robotics Tested in Living Animals

The team advanced their research by testing CiliaVine in living rabbits with liver tumors. The tiny hairy robot was inserted into a major vein through a catheter and operated using magnetic fields for 20 minutes1

1

. Examined vessel sections showed no reported signs of inflammation or tissue damage, suggesting the device could be safe for use inside blood vessels. While this biomedical robotics technology has not yet been tested as a treatment or diagnostic tool in human patients, the animal studies provide early safety data that could support future clinical trials. Watch for human trials that could validate whether CiliaVine can deliver on its promise to transform how doctors deliver drugs, dissolve clots, and monitor cancer progression directly within the bloodstream.